RJA
ARA

Raymond James & Associates’s American Renal Associates Holdings, Inc ARA Stock Holding History

Raymond James & Associates’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-22,333
Closed -$148K – 3708
2020
Q1 		$148K Sell
22,333
-26,550
-54% -$231K ﹤0.01% 3125
2019
Q4 		$507K Buy
48,883
+8,589
+21% +$73.4K ﹤0.01% 2734
2019
Q3 		$255K Buy
40,294
+18,000
+81% +$134K ﹤0.01% 3105
2019
Q2 		$166K Buy
+22,294
New +$147K ﹤0.01% 3321

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Raymond James & Associates's ARA Position: Q2 2020 in Review

Raymond James & Associates sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2020, closing a stake of 22,333 shares — an estimated $148K sold.

Raymond James & Associates first reported a position in ARA in Q2 2019 and held it in 4 quarters. The position peaked at $507K in Q4 2019. 56 funds tracked by Wall St. Rank hold ARA as of Q2 2020.

  • Raymond James & Associates reported no remaining American Renal Associates Holdings, Inc position as of Q2 2020 after selling out during the quarter.
  • Raymond James & Associates sold 22,333 American Renal Associates Holdings, Inc shares in Q2 2020, an estimated $148K.
  • Raymond James & Associates first reported a position in American Renal Associates Holdings, Inc in Q2 2019 and held it in 4 quarters.
  • Raymond James & Associates's American Renal Associates Holdings, Inc position peaked at $507K in Q4 2019.
  • 56 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2020.

Based on Raymond James & Associates's 13F filing for Q2 2020, filed 28 Jul 2020.